Stem cells and growth factors are effective at treating diabetic foot ulcers. Improved treatment protocols required for ...
Rising diabetes-related wounds, government-backed bioelectronics research, and real-time wound monitoring technologies accelerate global market expansion through 2033.Austin, Texas, Dec. 15, 2025 ...
HYDERABAD: Doctors have raised concern over the rising number of foot amputations in the state, with experts observing that ...
CMS spending on skin substitutes is rising. New policies are an important first step in reform to ensure patient access and ...
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease. The study has enrolled a total of 65 participants in the US, Europe and Australia ...
Cynata Therapeutics has achieved a major catalyst for 2025 by completing patient enrolment in its Phase II clinical trial of ...
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease. The study has enrolled ...
TipRanks on MSN
Cynata completes enrollment in phase 2 aGVHD trial
The latest announcement is out from Cynata Therapeutics Limited ( ($AU:CYP) ). Cynata Therapeutics has completed patient enrollment in its Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback